Boston Scientific Puts Up $275M For Bard Cardiac Unit

Law360, New York (June 28, 2013, 1:12 PM EDT) -- Medical device manufacturer Boston Scientific Corp. will put up $275 million for the electrophysiology unit of rival C.R. Bard Inc. in a deal that will give it a bigger slice of a fast-growing market for products that treat patients with abnormal heartbeats, it said Friday.

Under the terms of the sale agreement, Boston Scientific will make an upfront cash payment for the entire consideration when the deal closes, expected sometime during the back half of 2013. The company did not sketch out its financing plans, but...
To view the full article, register now.